Financial report interval: 2025.01.30 - 2025.04.30
Overview: Enzo Biochem, Inc.(ENZB) the Revenue is 6.402 M (-20.19%);the EBIT is -3.389 M (-65.88%);the EPS is -0.0532 (+9.71%).